- Sacral Neuromodulation in Patients With a Cardiac Pacemaker
-
Gahzi AA, Elterman D, Hassouna M
- KMID: 2365722
- Int Neurourol J.
- 2016 Sep;20(3):270-272.
- doi: 10.5213/inj.1632536.268
The objective of this study was to describe our experience using sacral neuromodulation to treat urinary urgency, frequency, urge incontinence, and chronic urinary retention in patients with cardiac pacemakers. With... -
- CITED
-
- Close
- SHARE
-
- Close
- Radiographic Position of the Electrode as a Predictor of the Outcome of InterStim Therapy
-
Gahzi AA, Banakhar M, Elterman D, Hassouna M
- KMID: 2400896
- Int Neurourol J.
- 2017 Dec;21(4):289-294.
- doi: 10.5213/inj.1734942.471
PURPOSE: Sacral neuromodulation (SNM) therapy is indicated for some refractory urological conditions. The electrode lead position in sacral x-rays during routine follow-up may predict the outcome of SNM therapy. To... -
- CITED
-
- Close
- SHARE
-
- Close
- Percutaneous Nerve Evaluation Test Versus Staged Test Trials for Sacral Neuromodulation: Sensitivity, Specificity, and Predictive Values of Each Technique
-
Banakhar M, Hassouna M
- KMID: 2365719
- Int Neurourol J.
- 2016 Sep;20(3):250-254.
- doi: 10.5213/inj.1630498.249
PURPOSE: InterStim device is an U.S. Food and Drug Administration approved minimal invasive therapy for sacral neuromodulation for lower urinary tract dysfunction. Before InterStim implantation, a trial with the appropriate... -
- CITED
-
- Close
- SHARE
-
- Close
